Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Mapping of the discontinuous kininogen binding site of prekallikrein. A distal binding segment is located in the heavy chain domain A4.

Herwald H, Renné T, Meijers JC, Chung DW, Page JD, Colman RW, Müller-Esterl W.

J Biol Chem. 1996 May 31;271(22):13061-7.

PMID:
8662705
2.

Mapping of the discontinuous H-kininogen binding site of plasma prekallikrein. Evidence for a critical role of apple domain-2.

Renné T, Dedio J, Meijers JC, Chung D, Müller-Esterl W.

J Biol Chem. 1999 Sep 3;274(36):25777-84.

PMID:
10464316
3.

Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain.

Herwald H, Jahnen-Dechent W, Alla SA, Hock J, Bouma BN, Müller-Esterl W.

J Biol Chem. 1993 Jul 5;268(19):14527-35.

PMID:
7686159
4.

Fine mapping of the H-kininogen binding site in plasma prekallikrein apple domain 2.

Renné T, Sugiyama A, Gailani D, Jahnen-Dechent W, Walter U, Müller-Esterl W.

Int Immunopharmacol. 2002 Dec;2(13-14):1867-73.

PMID:
12489801
5.

High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies.

Hock J, Vogel R, Linke RP, Müller-Esterl W.

J Biol Chem. 1990 Jul 15;265(20):12005-11.

PMID:
1694851
7.
8.

Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.

Page JD, You JL, Harris RB, Colman RW.

Arch Biochem Biophys. 1994 Oct;314(1):159-64.

PMID:
7944388
9.

Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor.

Herwald H, Dedio J, Kellner R, Loos M, Müller-Esterl W.

J Biol Chem. 1996 May 31;271(22):13040-7.

PMID:
8662673
10.

Identification of an endothelial cell binding site on kininogen domain D3.

Herwald H, Hasan AA, Godovac-Zimmermann J, Schmaier AH, Müller-Esterl W.

J Biol Chem. 1995 Jun 16;270(24):14634-42.

PMID:
7540175
11.

The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy.

Weisel JW, Nagaswami C, Woodhead JL, DeLa Cadena RA, Page JD, Colman RW.

J Biol Chem. 1994 Apr 1;269(13):10100-6.

PMID:
8144509
12.

A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface.

Veloso D, Silver LD, Hahn S, Colman RW.

Blood. 1987 Oct;70(4):1053-62.

PMID:
2443201
13.

Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein.

Renné T, Gailani D, Meijers JC, Müller-Esterl W.

J Biol Chem. 2002 Feb 15;277(7):4892-9.

PMID:
11733491
15.
16.

Mapping of the H-kininogen binding site exposed by the prekallikrein heavy chain.

Herwald H, Hock H, Jahnen-Dechent W, Müller-Esterl W.

Agents Actions Suppl. 1992;38 ( Pt 1):225-32. No abstract available.

PMID:
1466274
17.
18.

Structural dissection of the multidomain kininogens. Fine mapping of the target epitopes of antibodies interfering with their functional properties.

Kaufmann J, Haasemann M, Modrow S, Müller-Esterl W.

J Biol Chem. 1993 Apr 25;268(12):9079-91.

PMID:
7682558
20.

Parallel mechanisms of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions.

Olson ST, Francis AM, Sheffer R, Choay J.

Biochemistry. 1993 Nov 16;32(45):12148-59.

PMID:
8218292
Items per page

Supplemental Content

Support Center